Galactosemia unsolved

European Journal of Pediatrics

Volumn 154, Issue 2 Supplement, 1995, Pages

  Segal, Stanton ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Chronic intoxication; Complications; Endogenous galactose; Galactose metabolism

Indexed keywords

COMPLICATION; CONFERENCE PAPER; DIET; GALACTOSEMIA; HUMAN; MENTAL DEFICIENCY; NEUROLOGIC DISEASE; OVARY FUNCTION; PRIORITY JOURNAL; PROGNOSIS; SPEECH DISORDER;

GALACTOSEMIAS; HUMAN;

EID: 0029127425     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/BF02143813     Document Type: Article

References (78)

1. Early morning urine galactitol levels in relation to galactose intake: a possible method of monitoring the diet in galactokinase deficiency
2. Galactonic acid in galactosemia: identification in the urine
3. Galactose metabolism in isolated perfused suckling-rat liver
4. Red blood cell uridine sugar nucleotide levels in patients with classic galactosemia and other metabolic disorders
5. The effect of dietary fruits and vegetables on urinary galactitol excretion in galactose-1-phosphate uridyltransferase deficiency
6. Reduction in oocytes number following prenatal exposure to a diet high in galactose
7. Galactose conversion to d-xylulose: an alternate route of galactose metabolism
8. Defective galactosylation of proteins in cultured skin fibroblasts from galactosemic patients
9. Galactose-1-phosphate in galactosaemia
10. A molecular approach to galactosemia
11. Galactose-1-phosphate uridyltransferase: identification of histidine-164 and histidine-166 as critical residues by site-directed mutagenesis
12. Developmental aspects of galactosemia from infancy to childhood
13. Sequence of a cDNA encoding human galactose-1-phosphate uridyltransferase
14. Late onset neurologic syndromes in galactosemic siblings
15. Formation of galactose-1-phosphate from uridine diphosphate galactose in erythrocytes from patients with galactosemia
16. Galactose biogenesis and disposal in galactosemics
17. Galactitol excretion in the urine of a galactokinase-deficient man
18. Galactitol and galactose-1-phosphate in the lens of a galactosemic infant
19. Biogenesis of galactose, a possible mechanism of self-intoxication
20. The effect of polyol pathway inhibition and dietary myoinositol on glomerular hemodynamic function in experimental diabetes mellitus in the rat
21. Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes
22. Fruits and vegetables are a source of galactose: implications in planning the diets of patients with galactosaemia
23. Effect of galactose toxicity on growth of the rat fetus and brain
24. Regulation of galactose-1-phosphate uridyltransferase gene expression
25. Further observations in a case of uridine diphosphate galactose-4-epimerase deficiency with a severe clinical presentation
26. Galactose disorders. An overview
27. Effects of galactosemia in utero
28. Variability in the clinical manifestations of galactosemia
29. Accumulation of galactose-1-phosphate in the galactosaemic fetus despite maternal milk avoidance
30. Galactitol in galactosemia
31. Dietary restriction of maternal lactose intake does not prevent accumulation of galactitol in the amniotic fluid of fetuses affected with alactosaemia
32. Hypergonadotropic hypogonadism in female patients with galactosemia
33. Treatment of patients (PTS) with classical galactosemia (G) with oral uridine
34. The investigation of UDPGlucose and UDPGalactose concentration in red blood cells of patients with classical galactosaemia
35. Cataract in galactosemia
36. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors
37. Galactosemiathirty years on. The experience of a generation
38. The human galactose-1-phosphate uridyltransferase gene
39. Galactokinase deficiency presenting as pseudotumor cerebri
40. Curious neurologic sequelae in galactosemia
41. Chronic galactosemia
42. The enzymic interconversion of uridine diphosphogalactose and uridine diphosphoglucose
43. Deficit of uridine diphosphate galactose in galactosaemia
44. Abnormal galactosylation of complex carbohydrates in fibroblasts from patients with galactose-1-phosphate uridyltransferase deficiency
45. Progesterone effects on galactose metabolism in prepubertal patients with congenital galactosemia and in rats maintained on high galactose diets
46. The distribution of galactitol in tissues of rats fed galactose
47. Galactitol in the tissues of a galactosemic child
48. Galactose oxidation in liver
49. Cloning and characterization of a cDNA encoding human galactose-1-phosphate uridyltransferase
50. Molecular basis of galactosemia: mutations and polymorphisms in the gene encoding human galactose-1-phosphate uridyltransferase
51. Molecular characterization of two galactosemia mutations: correlation of mutations with highly conserved domains in galactose-1-phosphate uridyltransferase
52. Urinary galactitol in galactosemic patients
53. Enhanced galactose metabolism in isolated perfused livers of folate-treated suckling rats
54. Long-term outcome in 134 patients with galactosaemia
55. The negro variant of congenital galactosemia
56. Disorders of galactose metabolism
57. Defective galactosylation in galactosemia: is low cell UDP-galactose an explanation?
58. Observations on cataract formation in the newborn offspring of rats fed a high-galactose diet
59. Some observations on the metabolism of D-galactose in normal man
60. The oxidation of 14C galactose by patients with congenital galactosemia: evidence for a direct oxidative pathway
61. The metabolism of galactose by patients with congenital galactosemia
62. Liver galactose-1-phosphate uridyl-transferase: activity in normal and galactosemic subjects
63. Galactokinase deficiency and mental retardation
64. Hypogonadism and galactosaemia
65. Inositol changes in nerve and lens of galactose fed rats
66. Purification, stabilization, and properties of bovine mammary UDP-galactose 4-epimerase.
67. Formation of polyols by the lens of the rat with “sugar” cataracts
68. The effects of aldose reductase inhibition on nerve sorbitol and myo-inositol in diabetic and galactosemic rats
69. Galactonolactone in experimental galactosemic animals
70. Long-term prognosis in galactosemia: Results of a survey of 350 cases
71. Myo-inositol and phosphatidylinositol in synaptosomes from galactose-fed rats
72. Galactose toxicity and myo-inositol metabolism in the developing rat brain